📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Tissue engineering's green shoots of disruptive innovation. (2014)

First Author: Birchall MA

Attributed to: RegenVOX: phase I/II clinical trial of stem cell based tissue engineered laryngeal implants funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(14)60533-x

PubMed Identifier: 24726476

Publication URI: http://europepmc.org/abstract/MED/24726476

Type: Journal Article/Review

Volume: 384

Parent Publication: Lancet (London, England)

Issue: 9940

ISSN: 0140-6736